Ultimately, the study showed that 40% of patients taking HUMIRA achieved and maintained remission at 26 weeks,* and 36% of those patients achieved and maintained remission at 56 weeks. Individual results may vary. *Compared to 17% taking placebo.

If you're ready to take the next step toward achieving remission, ask your doctor if HUMIRA could be right for you. HUMIRA is approved to treat moderate to severe Crohn's disease & ulcerative colitis.

Humira is an injectable medication that belongs to a group of medications called biologics. Biologic drugs like Humira help reduce inflammation and manage symptoms of Crohn's by blocking the inflammatory reactions in your body. This can help ease Crohn's symptoms and assist with disease remission.

Entyvio pre-filled pen for subcutaneous injection contains the active ingredient vedolizumab. Entyvio is used to treat the signs and symptoms of moderate to severe ulcerative colitis or moderate to severe Crohn's disease in adults who have not responded well enough or are intolerant to other treatments.

Always follow your doctor's instructions about when and how often to use Humira. Your dose for Humira can also vary and depends on the condition being treated. However, many patients stay on Humira for years. In some cases, your doctor may decide to lower your dose or stop your treatment all together.

It's possible for Humira treatment to cause long-term side effects. For example, the drug has caused growth of new cancers. It has also caused existing tumors (masses of cancerous tissue) to grow. In fact, Humira has a boxed warning about risk of cancer.

Always follow your doctor's instructions about when and how often to use Humira. Your dose for Humira can also vary and depends on the condition being treated. However, many patients stay on Humira for years. In some cases, your doctor may decide to lower your dose or stop your treatment all together.

In Crohn's disease or ulcerative colitis, some adults may start to see results within 4 weeks after starting Humira treatment, but most people see an improvement by 8 weeks. In adults with Crohn's disease, roughly one-third of patients may achieve remission (few or no symptoms) by 4 weeks after starting treatment.

Deltasone (prednisone), Medrol (methylprednisolone), and Entocort EC (budesonide) are corticosteroids commonly prescribed for Crohn's disease. Corticosteroids suppress the entire immune system, not just in the digestive tract.

Understanding the costs of Crohn's disease. A 2019 study from the Crohn's & Colitis Foundation found that people with Crohn's typically incur about $30,000 in care costs in the year of their initial diagnosis. “Everyone's a little different, and there are patients who are much tougher to induce into initial remission.

It's possible for Humira treatment to cause long-term side effects. For example, the drug has caused growth of new cancers. It has also caused existing tumors (masses of cancerous tissue) to grow. In fact, Humira has a boxed warning about risk of cancer.

The drug is popular with patients but has a list price of nearly $7,000 a month, according to GoodRx, a website that helps patients find discounts on pharmaceuticals. Even with insurance, the drug, made by AbbVie, can be quite expensive.